More stories

  • in

    US Emergency Departments Are Overstretched and Doctors Burned Out

    The Fair Observer website uses digital cookies so it can collect statistics on how many visitors come to the site, what content is viewed and for how long, and the general location of the computer network of the visitor. These statistics are collected and processed using the Google Analytics service. Fair Observer uses these aggregate statistics from website visits to help improve the content of the website and to provide regular reports to our current and future donors and funding organizations. The type of digital cookie information collected during your visit and any derived data cannot be used or combined with other information to personally identify you. Fair Observer does not use personal data collected from its website for advertising purposes or to market to you.As a convenience to you, Fair Observer provides buttons that link to popular social media sites, called social sharing buttons, to help you share Fair Observer content and your comments and opinions about it on these social media sites. These social sharing buttons are provided by and are part of these social media sites. They may collect and use personal data as described in their respective policies. Fair Observer does not receive personal data from your use of these social sharing buttons. It is not necessary that you use these buttons to read Fair Observer content or to share on social media. More

  • in

    Why is the American right suddenly so interested in psychedelic drugs? | Ross Ellenhorn and Dimitri Mugianis

    Why is the American right suddenly so interested in psychedelic drugs?Ross Ellenhorn and Dimitri MugianisMagic mushrooms are no magic cure for society’s ills, and a substance as powerful as psychedelics can be dangerous if it falls into the wrong hands Psychedelic therapies are receiving unprecedented financial and political support – and much of it comes from the right. Peter Thiel has invested extensively in the emerging psychedelic therapeutic industry. Jordan Peterson is a psilocybin fan. In 2018, the Mercer Foundation donated $1m to the Multidisciplinary Association for Psychedelic Studies (Maps), the leading US psychedelics research organization, for studies of MDMA treatment of PTSD in veterans.The Mercer family also supports the American right wing and climate crisis denial. They’re a long way from Woodstock – but Maps and some other psychedelic advocates seem glad for any support they can get.Democrats shouldn’t focus only on abortion in the midterms. That’s a mistake | Bernie SandersRead moreTo be sure, there are plenty of leftists and liberals who endorse the medical use of psychedelics. In July, Alexandria Ocasio-Cortez offered a successful amendment to the new $768bn defense spending bill to support increased research into psychedelic treatment for veterans and active-duty service members. So did Dan Crenshaw, a navy veteran and Republican representative from Texas. Matt Gaetz, Republican from Florida and noted misogynist, offered a similar amendment.Psychedelics have long been associated with utopian experiments. Today, some researchers dream of finding a scientific basis for the hypothesis that psychedelics might help end intractable political conflict. Last year, Maps and Imperial College London organized a joint ayahuasca trip for Israelis and Palestinians. In 2018, Imperial College received much attention for a tiny study suggesting that one dose of psilocybin therapy reduced support for “authoritarian attitudes”. Could psychedelics be the cure for anti-democratic tendencies? Rick Doblin, founder of Maps, has even suggested that psychedelic use could help stop environmental degradation.Psychedelics can certainly increase openness – but this can be openness to Nazism, eco-fascism or UFO cults as well as to peace and love. Julius Evola, an Italian philosopher and fascist admired by both Hitler and Steve Bannon, was a staunch LSD advocate. Governor Greg Abbott of Texas, who recently made headlines for sending buses of migrants to New York, Washington and Chicago, signed a 2021 state bill to study the medical benefits of psychedelics. Steve Bannon supports legalized psychedelics, too.As professors Brian Pace and Neşe Devenot point out in their work rebutting the science on psychedelics as a kind of medicine for authoritarianism, psychedelics have never had a purely leftwing fanbase. Andrew Anglin, the founder of the neo-Nazi website Daily Stormer, experimented extensively with psychedelics in his youth. The founder of 8chan, the now-defunct extremist message board that hosted the manifestos of several mass shooters, was inspired by a mushroom trip.Why is the American right so intrigued by these substances today? The most obvious answer is money. As psychedelics are absorbed into mainstream medicine, they promise to become another American cash cow. Money will come from patents on novel formulations and by patenting and providing the associated treatment techniques.There may be political factors at play, as well. Was the Mercer Foundation’s donation to Maps motivated by a desire to shore up American military resources by palliating the harms suffered by those sent to fight those wars? The military-industrial complex is even more lucrative than the pharmaceutical sector, but those weapons still require human beings to deploy them. Is rightwing psychedelic funding an attempt to ensure the continued viability of American wars around the world?And, if MDMA is so helpful in the treatment of PTSD, why are veterans given special priority in a society that has traumatized so many people? What about the trauma of racism, of poverty, of police violence and mass incarceration – problems actively increased by rightwing policies supported by people like the Mercers?Psychedelics have the potential to help people break out of repetitive, destructive thoughts, to help them discover new possibilities and new joy. But the effects of psychoactive drugs can never be detached from their setting.It’s foolish to imagine positive transformation achieved with the help of Rebekah Mercer, Steve Bannon or Greg Abbott. After all, these are the same people who vociferously oppose universal healthcare and deny climate change. With their support, we can expect psychedelic medicine for the elite, as a tool of state power or an engine of conspiracy theories, rather than a liberationist psychedelic movement. Until we have universal, single-payer healthcare, the benefits of psychedelic therapy will be out of reach for most Americans.And it’s naïve to expect psychedelics to change your mind for the better (in Michael Pollan’s formulation) when they’re a gift of the right wing, or when they’re offered within a framework of gross inequality. Look at Burning Man: this pseudo-utopia has become a playground of Silicon Valley’s ultra-rich. It leaves the desert strewn with thousands of abandoned bicycles and produces 12-hour traffic jams in the desert – which is hotter than ever thanks to our profligate burning of fossil fuels. With the wrong company, a journey of self-discovery can lead to even deeper solipsism. In fact, the illusion of transcendence can be used to justify greater selfishness, even cruelty.Psychedelic therapies – like all other forms of care – should be available to those who need them, not only to those with money and connections and political utility. In the psychedelic community there’s a lot of talk about “integration”, a processing of your trip. But this “integration” is too often limited to the individual. To be truly beneficial, psychedelics should be integrated into a social vision of equality and justice, one that opposes the sacrifice of human life and health at the altar of military spending and empire building, one that values every life regardless of race, nationality, religion, gender or class.Magic mushrooms are no magic cure for society’s ills, and a substance as powerful as psychedelics can be dangerous if it falls into the wrong hands. Psychedelic advocates need to stop cozying up to the right and expand their mission to encompass a commitment to broader social justice.
    Ross Ellenhorn is a sociologist, psychotherapist and author and the founder and CEO of Ellenhorn. His new book, Purple Crayons: The Art of Drawing a Life, is out on 1 November. Dimitri Mugianis is a harm reductionist, activist, musician, poet, writer, and anarchist, with over two decades of experience as a psychedelic practitioner. Ellenhorn and Mugianis are the founders of Cardea
    TopicsUS politicsOpinionMedical researchPeter ThielSteve BannonGreg AbbottHealthcommentReuse this content More

  • in

    ‘Artemis generation’: Nasa to launch first crew-rated rocket to moon since 1972

    ‘Artemis generation’: Nasa to launch first crew-rated rocket to moon since 1972Test flight that will have no human crew aboard aims to return humans to the moon and eventually land them on Mars For the first time in 50 years, Nasa on Monday is planning to launch the first rocket that can ferry humans to and from the moon.The giant Space Launch System (SLS) rocket is scheduled to take off from Nasa’s Cape Canaveral, Florida, complex at 8.33am ET (1.33pm UK time) atop an unmanned Orion spacecraft that is designed to carry up to six astronauts to the moon and beyond.The 1.3m mile Artemis I test mission – slated to last 42 days – is aiming to take the Orion vehicle 40,000 miles past the far side of the moon, departing from the same facility that staged the Apollo lunar missions half a century ago.Artemis 1 rocket: what will the Nasa moon mission be carrying into space?Read moreNasa’s Space Shuttle program in the intermediary launched manned missions orbiting the earth in relatively near outer space before its discontinuation in 2011. Private American space companies such as Jeff Bezos’s Blue Origin and Elon Musk’s SpaceX have since flown missions similar to the shuttle program. But Artemis I’s job is to begin informing Nasa whether the moon can act as a springboard to eventually send astronauts to Mars, which would truly bring the stuff of science fiction to life.US taxpayers are expected to put up $93bn to finance the Artemis program. But in the days leading up to Monday’s launch, Nasa administrators insisted that Americans would find the cost to be justified.“This is now the Artemis generation,” the Nasa administrator and former space shuttle astronaut Bill Nelson said recently. “We were in the Apollo generation. This is a new generation. This is a new type of astronaut.”For Monday’s debut, the only “crew members” aboard Orion are mannequins meant to let Nasa evaluate its next-generation spacesuits and radiation levels – as well as a soft Snoopy toy meant to illustrate zero gravity by floating around the capsule.TopicsNasaSpaceThe moonMarsFloridaUS politicsnewsReuse this content More

  • in

    Convergent Conversation – In fact VR is Possible, Bill!

    The Fair Observer website uses digital cookies so it can collect statistics on how many visitors come to the site, what content is viewed and for how long, and the general location of the computer network of the visitor. These statistics are collected and processed using the Google Analytics service. Fair Observer uses these aggregate statistics from website visits to help improve the content of the website and to provide regular reports to our current and future donors and funding organizations. The type of digital cookie information collected during your visit and any derived data cannot be used or combined with other information to personally identify you. Fair Observer does not use personal data collected from its website for advertising purposes or to market to you.As a convenience to you, Fair Observer provides buttons that link to popular social media sites, called social sharing buttons, to help you share Fair Observer content and your comments and opinions about it on these social media sites. These social sharing buttons are provided by and are part of these social media sites. They may collect and use personal data as described in their respective policies. Fair Observer does not receive personal data from your use of these social sharing buttons. It is not necessary that you use these buttons to read Fair Observer content or to share on social media. More

  • in

    DC Deconstructed: The View from the Carriage House

    The Fair Observer website uses digital cookies so it can collect statistics on how many visitors come to the site, what content is viewed and for how long, and the general location of the computer network of the visitor. These statistics are collected and processed using the Google Analytics service. Fair Observer uses these aggregate statistics from website visits to help improve the content of the website and to provide regular reports to our current and future donors and funding organizations. The type of digital cookie information collected during your visit and any derived data cannot be used or combined with other information to personally identify you. Fair Observer does not use personal data collected from its website for advertising purposes or to market to you.As a convenience to you, Fair Observer provides buttons that link to popular social media sites, called social sharing buttons, to help you share Fair Observer content and your comments and opinions about it on these social media sites. These social sharing buttons are provided by and are part of these social media sites. They may collect and use personal data as described in their respective policies. Fair Observer does not receive personal data from your use of these social sharing buttons. It is not necessary that you use these buttons to read Fair Observer content or to share on social media. More

  • in

    The Great Fever Misconception

    Yes or no? On or off? Zero or one? Binary is simple, and simple is good. It facilitates decision-making, especially in a crisis like a pandemic. After all, either you have COVID-19 or you don’t. If you have COVID, then you are infectious and should isolate to avoid spreading it. On the other hand, if you don’t have COVID, you can’t infect anyone else, no matter how closely you associate with them. Of course, the tricky part is determining whether or not someone has COVID.

    The PCR test is the gold standard for determining if a person has COVID-19. It’s a very good test that gives us the yes-or-no binary information that we value so much for making decisions. Unfortunately, the test is not always readily available and it’s also expensive. And timing is critical. If you take the test too soon after you are infected, the virus may not have yet traveled to your nose where the sample is taken, and thus the result may be a false negative — you have COVID but the test indicates you don’t. Also, it often takes time in a laboratory to process the results — will you isolate or carry on while you’re waiting?

    COVID Failure: A Matter of Principle

    READ MORE

    Finally, what would prompt you to get a COVID test? Perhaps some event prompts you or requires a test by policy, but otherwise, you might take a test because you feel sick. If so, you already know you may be infectious. In that case, a positive COVID test merely confirms what you already suspect, and you normally get that confirmation a couple of days too late to do any good. Despite our heavy reliance on testing, it’s not as simple or as timely as we would like for deciding when to isolate.

    We’ve had another way to separate the healthy from the sick during the COVID-19 pandemic: symptoms. For example, if you have a fever, then you may be infectious. But temperature-based screening has not been very effective at all, and a big reason why is that the US government has historically defined fever as 100.4°F (38°C) or above. If a person’s body temperature is 100.3°F, then according to the government, that person does not have a fever. Does that make sense?

    Unfortunately, one of the distinguishing characteristics of COVID is the tendency of many infected people to have mild or even unnoticeable symptoms, including only slightly elevated body temperature, below 100.4°F. So, the government’s definition of “fever,” although simple and binary, has only confused the situation. Some people who were asymptomatic with COVID-19 took their temperature, found it to be below 100.4°F and assumed they did not have a fever. So, they carried on with normal day-to-day activities, often infecting others. Temperature-based screening systems typically use the government’s 100.4°F fever threshold, and, as a result, failed to prevent entry by many infected persons. Relying on the government’s 100.4°F fever definition has contributed to the spread of COVID-19. Where did this government standard come from, how can it be improved, and why has the US resisted change?

    © Douglas Dyer

    Origins of 100.4°F

    In 1868, a German physician, psychiatrist and medical professor named Carl Reinhold August Wunderlich published a paper describing his assessment that normal body temperature is relatively constant, varies from 97.9°F to 99.3°F (36.6°C to 37.4°C), and averages 98.6°F (37°C). He found that patients with a disease often exhibited a symptom of fever that he found to average at or above 100.4°F. He based these findings on 1 million temperature measurements for 25,000 patients.

    For the time, this scientific result was quite remarkable, and it changed medicine forever because it gave physicians the newfound ability to objectively assess the presence and severity of many diseases. However, Wunderlich’s patients were mostly German rather than being from different cultures, his thermometer may have been less accurate than those we have today, and people are a little different now than they were then.

    These are reasons to suspect that Wunderlich’s ideas of normal body temperature and fever are somewhat different today than they were in the mid-1800s. But, to be fair, Wunderlich observed differences in temperature based on many variables when healthy, and he advised that temperature averages have many “shades of gray.” In particular, Wunderlich noted that even smaller rises in temperature are cause for concern, and that there is no definite temperature threshold over which a person transitions from health to sickness. He said that any “elevation of the axillary [under the arm] temperature above 99.5°F (37.5°C) or any depression below 97.2°F (36.5°C) is always very suspicious.” He added: “But even when every precaution has been taken in making the observations, it is impossible to draw a hard and fast line to indicate by temperature the exact limits of health and disease.”

    © Douglas Dyer

    Today, clinical research suggests that Wunderlich’s findings should be revisited, that the normal temperature range varies by the individual, and that there is no arbitrary fever threshold that works for everyone. Yet, the US government and some medical experts still regard 98.6°F as normal body temperature and 100.4°F or above as a fever. For COVID019, this is simple, easy and, for most people, wrong.

    Improving on 100.4°F as a Fever Threshold

    If you’re interested in seeing if 100.4°F is an appropriate fever threshold for you, try taking your temperature. Use a normal, digital, under-the-tongue thermometer for at least 60 seconds. Make sure you haven’t consumed anything for 15 minutes — a hot or cold drink or food will change your measurement. Keep your mouth closed during the reading. Assuming you are healthy, if your temperature is below 98.6°F, then it’s a good bet that your fever threshold is under 100.4°F.

    If you were to take your temperature every day, preferably in the morning when you first wake, you would see that your normal temperature varies in a range of one degree or so. For example, in the image below is the normal temperature data for a person we’ll call JRDA5.

    © Douglas Dyer

    From this graph, we can see that JRDA5’s normal body temperature varies from 96.6°F to 97.4°F when healthy, and you can expect your own normal temperature to vary also.

    In modern medicine, a fever is understood to be a temperature elevation above a person’s normal range. This definition of fever is more accurate than an arbitrary fever threshold like 100.4°F that is based on population averages and data from 150 years ago. A person’s normal temperature range depends on many factors such as age, sex, nutrition and level of activity, and so different people will have different fever thresholds.

    Almost always, a fever threshold defined as above your normal temperature range is below 100.4°F. Therefore, if we use this new definition, there is significant potential for identifying sick people using temperature-based screening. Relying on 100.4°F is insufficient for identifying mild, pre-symptomatic or asymptomatic cases of COVID-19.

    Why the Government Has Resisted Changing the Definition of “Fever”

    A pandemic is not the best time for complicated methods. Perhaps the US government chose to stick with 100.4°F for simplicity and consistency. But, in this pandemic, nothing has been simple. We’ve learned to take advantage of vaccines that need boosting, tests that need repeating and symptoms that keep changing. People can figure out their normal temperature range and their own personal fever threshold if that means effective screening. Having a fever or not is still binary, even if we define fever as above your normal range. It’s still pretty simple.

    Elevated temperature is not definitive proof you have COVID-19. We all like certainty, and the PCR test will remain the gold standard for COVID. But we don’t need certainty to make a decision to isolate. A fever should prompt isolation, even though it may not be caused by COVID. The next step is to get tested and then wait for the results. We can stop the pandemic if people isolate if they get a fever. Fever is the most timely indicator we may be infectious.

    Asymptomatic cases may not exhibit any elevated temperature, so we cannot depend on temperature screening anyway. It’s possible that there are some people infected with COVID-19 who do not have any fever, perhaps because their immune system doesn’t work at all. However, we know that many asymptomatic cases are accompanied by elevated body temperature lower than 100.4°F. We can catch those people using the more correct definition of fever. The perfect should not be the enemy of the good.

    Unique Insights from 2,500+ Contributors in 90+ Countries

    People hate change and the government is no different. It takes a lot to pass federal legislation and to modify federal regulations. But the government’s 100.4°F fever threshold isn’t working. The effort to change will help us control the pandemic.

    How Redefining “Fever” Helps

    Since the omicron variant of COVID-19 emerged, we’ve seen increased demand for testing, with many people standing in line for hours waiting to get a test. In the United States, the government has been ordering more tests to address the shortages. However, the demand for testing can evidently overrun our testing resources. By using a more accurate definition of “fever,” people will have a better idea of when they need to get tested. Today, about 75% of tests come back negative. We have clinical evidence that fever and other readily available health data can predict test results. By redefining “fever,” we can make testing more efficient.

    We can also monitor our health every day, conveniently, in our own homes. We can’t afford to give everyone a daily PCR test, and hardly anyone wants that anyway. In contrast, it’s easy, fast and affordable to take our temperature every day. It’s a smart, safe way to help keep our friends and family safe and do our part to fight the pandemic. A lot of people would self-monitor if they knew it would help.

    The coronavirus that causes COVID-19 evidently mutates easily, giving rise to variants, and we don’t expect that to change. It’s possible there are already variants that are not caught by current tests. Redefining “fever” can help identify cases that PCR tests miss. So far, fever is a symptom of all variants. More broadly, fever is a symptom of many other infectious illnesses, such as the flu. Isolating when you have a fever is appropriate for new variants and other viruses to help prevent the spread and keep everyone safer.

    It’s high time for the government to redefine “fever” as body temperature above a person’s normal, healthy range. With a more accurate definition, temperature-based screening can be a powerful new tool for fighting the pandemic — and one well-suited to use by anyone, at home and in time to make a difference. Americans want to help fight the pandemic. It’s about time the government helps them do just that.

    The views expressed in this article are the author’s own and do not necessarily reflect Fair Observer’s editorial policy. More

  • in

    Test to Treat: pharmacists say Biden’s major new Covid initiative won’t work

    Test to Treat: pharmacists say Biden’s major new Covid initiative won’t workProgram to facilitate access to antivirals will have a limited impact because pharmacists are restricted from prescribing the pills A major new Biden administration initiative to facilitate access to Covid-19 antivirals will have a limited impact and fail to mitigate certain health inequities, major pharmacist groups argue, because pharmacists are restricted from prescribing the pills.Announced in Joe Biden’s State of the Union address, the “Test to Treat” program is meant to address the maddening difficulty Americans have had in accessing Covid-19 treatments. The administration will channel newly increasing stocks of antiviral pills to major retail pharmacies that have in-house clinics, providing one-stop testing and antivirals access.The program, which the administration aims to provide for free (in the face of fierce Republican opposition to new Covid-19 spending), is also slated to roll out in Veterans Affairs clinics, community health centers and long-term care facilities.Major participants include some 250 Walgreens stores, 225 Kroger Little Clinics and 1,200 CVS MinuteClinics. CVS clinics in particular are staffed by nurse practitioners and physician assistants, authorized by the Food and Drug Administration (FDA) to prescribe the two currently available Covid antivirals, Pfizer’s Paxlovid and Merck and Ridgeback Biotherapeutics’ molnupiravir.In a 9 March letter to Biden calling for pharmacists to be granted authority to prescribe these pills, 14 organizations representing pharmacies and pharmacists insisted Test to Treat’s impact will be compromised by the fact that such in-house clinics are relatively limited in number and largely in urban areas.“Unfortunately, rural and underserved communities are less likely to benefit from your test to treat approach because of this limitation,” the letter states.According to the Centers for Disease Control and Prevention (CDC), 90% of Americans live within five miles of one of approximately 60,000 pharmacies.“The FDA is still blocking us from leveraging the most accessible healthcare provider out there to make sure that these patients can get these drugs easily,” said Michael Ganio, a Columbus, Ohio pharmacist, senior director of pharmacy practice and quality at the American Society of Health-System Pharmacists, which is a signatory of the letter to Biden.“As far as expanding access,” said Ganio, Test to Treat is “not doing a lot”.The need for Covid-19 antivirals is likely to be greater in rural areas, at least on a per-capita basis. A recent CDC study found that through January, 58.5% of people aged five and older in rural counties had received at least one coronavirus vaccination shot, compared with 75.4% in urban counties.Paxlovid and molnupiravir are authorized for individuals at high risk of severe Covid-19, in particular unvaccinated people with certain medical conditions. Paxlovid was 88% effective at preventing hospitalization and death in its clinical trial. Molnupiravir proved just 30% effective. The FDA only authorizes its use when other treatments are unavailable or aren’t advised for an individual.Sufficient supply of Paxlovid will be key to Test to Treat. Since late December, the federal government has delivered a woefully inadequate 700,000 Paxlovid courses to states, the biweekly allotment increasing from 100,000 in January to 175,000 in March.The administration has claimed it will distribute 1m courses in March and 2.5m in April. A Pfizer representative would only state that the company plans to deliver a cumulative 10m courses by the end of June. The administration has agreed to purchase 20m courses, slated to be delivered by the end of September.In September 2021, the US Department of Health and Human Services amended a federal public health emergency law, the Prep Act, to grant licensed pharmacists the authority “to order and administer select Covid-19 therapeutics” – which at the time meant monoclonal antibodies and vaccines.But when the FDA authorized Paxlovid and molnupiravir in December, it explicitly restricted pharmacists from prescribing them.Authors of the letter to Biden say they submitted data to the FDA at the end of January, hoping to persuade it to grant pharmacists prescribing authority.These groups have also lobbied the federal government to ensure Medicare Part B would reimburse pharmacists for such prescribing – a move that would probably lead health insurers to follow.Prescribing Paxlovid safely can be challenging, because it may interact harmfully with other medications. Additionally, the FDA advises against providing the treatment to those with severe kidney or liver impairment. Experts have also raised concerns about molnupiravir’s potential toxicities. It cannot be prescribed to minors and is not advised for pregnant women.Chanapa Tantibanchachai, an FDA press officer, said the agency’s decision to forbid pharmacists from prescribing Paxlovid and molnupiravir “was based on several factors, including the drugs’ side-effect profiles, the need to assess potential for drug interactions, the need to assess potential kidney function problems (including the severity of potential problems), and the need to evaluate patients for pre-existing conditions” linked to severe Covid-19.Tantibanchachai said the FDA could revise the policy “as new data and information become available”.On 4 March, the American Medical Association said the “pharmacy based clinic component of the Test to Treat plan flaunts patient safety and risks significant negative health outcomes”. The AMA argued that by prescribing Covid antivirals at such clinics, providers may endanger patients for whom they lack a comprehensive medical history.The pharmacy groups insisted in their letter to Biden they have the expertise to prescribe these medications.In an email to the Guardian, Al Carter, executive director of the National Association of Boards of Pharmacy, stated: “Pharmacists have more complete access to the patients’ medication in comparison to physicians, especially since most patients have more than one prescriber, who don’t necessarily talk with each other.“Pharmacists spend their whole education focused on medications and their impacts on the body; whereas physicians take the minimal number of classes on pharmacology.”Katherine Yang, a clinical pharmacist at the University of California, San Francisco, said: “There are a lot of studies that show that when you increase services in community pharmacies, you improve care. In a lot of neighborhoods and rural areas, people may not have access to primary care, and pharmacists are the most accessible public health provider the patients can see.”TopicsCoronavirusBiden administrationUS domestic policyUS politicsPfizerPharmaceuticals industrynewsReuse this content More